Newly Funded Projects Aim to Improve Vaccine Use, Preventive Care in IBD

Newly Funded Projects Aim to Improve Vaccine Use, Preventive Care in IBD
Some $1 million in funding will go to three projects aimed at addressing gaps in vaccine use and communication among healthcare providers and patients with inflammatory bowel disease (IBD). Made possible through Pfizer Global Medical Grants (GMG), the recipients were announced by the American College of Gastroenterology (ACG), the Crohn’s & Colitis Foundation, and the American Gastroenterological Association (AGA). The GMG’s goal is to collaborate with the global healthcare community to improve patient outcomes. “These projects were selected for their potential to overcome barriers by helping to identify and establish best practices around improving vaccine utilization and preventive health maintenance for patients with IBD,” said a news release by Francis A. Farraye, MD, director of the Inflammatory Bowel Disease Center at Boston Medical Center, and chair of the steering committee for the organizations’ partnership. “The selected projects also have the potential to be easily replicated, broadly disseminated, and widely adopted within the IBD community.” The recipients are:  — Improving Vaccine Utilization and Preventive Health Maintenance in IBD. Led by Gil Y. Melmed, MD, of Cedars-Sinai Medical Center, the plan is to learn more about impediments to patient use of preventive care. To do this, the researcher will use patient focus groups and develop digital solutions, including an interactive website. Designed to overcome patient barriers, interventions will be tested through the IBD Partners Patient-Powered Research Network.  Influenza vaccinations will be the chief focus, followed by pneumococcal and zoster vaccination recommendation uptake, and tests for bone conditions and skin cancer.  If all goes well, the educational eff
Subscribe or to access all post and page content.